Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
We also had specific errors of commission in Zoetis and Workday, both of which have now been exited. Zoetis observed increased...
— Mike Poggi
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Zoetis Inc.
Zoetis ($ZTS) is a global leader in animal health, engaged in the discovery, development, and manufacture of veterinary pharmaceuticals, vaccines, and diagnostic products for livestock and companion animals. The manager divested...
Zoetis Inc. ($ZTS) is the global leader in animal health, producing specialized veterinary medicines, vaccines, and diagnostic tests for companion pets and livestock. Middle Coast initiated...
Zoetis Inc. is a dominant player in the animal health industry, but its capital allocation strategy has focused on share buybacks rather than organic growth. The com...
More institutional theses from Brown Advisors Global Leaders Strategy
The managers view London Stock Exchange Group as a successful turnaround following its acquisition of Refinitiv. Despite initial skepticism...
CRH is a major North American building materials company that has repositioned its business toward less cyclical, higher-margin growth markets while significantly reducing leverage. The company leverages...